Ballentine Partners LLC Has $1.47 Million Stock Position in SAP SE (NYSE:SAP)

Ballentine Partners LLC increased its holdings in shares of SAP SE (NYSE:SAP) by 16.7% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 6,403 shares of the software maker’s stock after acquiring an additional 914 shares during the quarter. Ballentine Partners LLC’s holdings in SAP were worth $1,467,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Godsey & Gibb Inc. bought a new stake in shares of SAP in the third quarter worth about $25,000. LRI Investments LLC acquired a new position in shares of SAP in the 1st quarter valued at approximately $25,000. POM Investment Strategies LLC increased its stake in SAP by 892.3% during the 2nd quarter. POM Investment Strategies LLC now owns 129 shares of the software maker’s stock worth $26,000 after purchasing an additional 116 shares in the last quarter. Crewe Advisors LLC raised its holdings in SAP by 1,270.0% during the 2nd quarter. Crewe Advisors LLC now owns 137 shares of the software maker’s stock worth $28,000 after buying an additional 127 shares during the period. Finally, Sunbelt Securities Inc. bought a new position in SAP in the first quarter valued at approximately $29,000.

Wall Street Analysts Forecast Growth

SAP has been the subject of several research reports. JMP Securities increased their price objective on shares of SAP from $245.00 to $300.00 and gave the stock a “market outperform” rating in a research report on Tuesday. BMO Capital Markets upped their price target on SAP from $248.00 to $265.00 and gave the stock an “outperform” rating in a research report on Tuesday. TD Cowen boosted their price objective on shares of SAP from $234.00 to $240.00 and gave the stock a “hold” rating in a research report on Tuesday. Barclays lifted their price target on shares of SAP from $252.00 to $275.00 and gave the company an “overweight” rating in a research note on Wednesday. Finally, Argus upgraded shares of SAP from a “hold” rating to a “buy” rating in a research note on Wednesday, July 31st. One research analyst has rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $252.33.

SAP Stock Down 0.2 %

Shares of SAP stock opened at $237.72 on Friday. SAP SE has a 52-week low of $130.63 and a 52-week high of $240.08. The stock has a market cap of $292.04 billion, a price-to-earnings ratio of 51.57, a PEG ratio of 4.42 and a beta of 1.25. The firm’s 50-day moving average is $223.18 and its 200-day moving average is $204.50. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.12 and a current ratio of 1.12.

SAP (NYSE:SAP) last released its quarterly earnings data on Monday, October 21st. The software maker reported $1.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.31 by ($0.08). The business had revenue of $8.47 billion during the quarter, compared to the consensus estimate of $9.25 billion. SAP had a net margin of 8.15% and a return on equity of 11.39%. SAP’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.20 EPS. Sell-side analysts predict that SAP SE will post 4.83 EPS for the current year.

SAP Profile

SAP SE, together with its subsidiaries, provides applications, technology, and services worldwide. It offers SAP S/4HANA that provides software capabilities for finance, risk and project management, procurement, manufacturing, supply chain and asset management, and research and development; SAP SuccessFactors solutions for human resources, including HR and payroll, talent and employee experience management, and people and workforce analytics; and spend management solutions that covers direct and indirect spend, travel and expense, and external workforce management.